Torthaí cuardaigh - Ina Müller

  • 1 - 5 toradh as 5 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes

    A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes de réir Niels Schaft, Jan Dörrie, Ina Müller, Verena Beck, Stefanie Baumann, Tanja Schunder, Eckhart Kämpgen, Gerold Schuler

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation

    Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation de réir Niels Schaft, Jan Dörrie, Peter Thumann, Verena Beck, Ina Müller, Erwin Schultz, Eckhart Kämpgen, Detlef Dieckmann, Gerold Schuler

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies

    Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies de réir Ilka Knippertz, Marcello F. Stein, Jan Dörrie, Niels Schaft, Ina Müller, Andrea Deinzer, Alexander Steinkasserer, Dirk M. Nettelbeck

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO show higher ADCC levels and improved event-free survival

    Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO show higher ADCC levels and... de réir Nikolai Siebert, Christian Fuglesang S. Jensen, Sascha Troschke‐Meurer, Maxi Zumpe, Madlen Jüttner, Karoline Ehlert, Silke Kietz, Ina Müller, Holger N. Lode

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)

    Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (A... de réir Jens Atzpodien, K. Neuber, Darab Kamanabrou, Michael Fluck, E B Bröcker, C. Neumann, Thomas M. Rünger, Gerold Schuler, Peter Von Den Driesch, Ina Müller, E. Paul, T Patzelt, Martina Reitz

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: